Transbronchial Lung Biopsy with Fluoroscopic Guidance

Diagnostic yield and Complications of Transbronchial Lung Biopsy with Fluoroscopic Guidance: A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150606022566N3

Enrollment

150

Registered

2018-10-30

Start date

2018-02-20

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parenchymal lung disease. chronic lower respiratory diseases

Interventions

Intervention 1: Intervention group: Transbronchial lung biopsy will perform using fiberoptic bronchoscopy under fluoroscopic–guidance. Intervention 2: Control group: Transbronchial lung biopsy will pe

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with pulmonary parenchymal lesions

Exclusion criteria

Exclusion criteria: patients with pulmonary parenchymal lesions with severe hypoxemia patients with pulmonary parenchymal lesions with severe refractory asthma patients with pulmonary parenchymal lesions with hemodynamic instability patients with pulmonary parenchymal lesions with malignant arrhythmia patients with pulmonary parenchymal lesions with severe hemoptysis

Design outcomes

Primary

Measure	Time frame
Overall diagnosis of lesions. Timepoint: during bronchoscopy. Method of measurement: fiberoptic bronchoscop.;Pneumothorax rate. Timepoint: After Bronchoscopy. Method of measurement: Chest X-Ray.;Bleeding rate. Timepoint: After Bronchoscopy. Method of measurement: Chest X-Ray.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Seyed Mehdi hashemi

Kerman University of Medical Sciences

Hashemimehdi70@yahoo.com+98 34 3132 8000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026